Cargando…
253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
BACKGROUND: The IDSA and NCCN guidelines recommend continuing IV anti-pseudomonal (IVPSA) therapy until neutrophil recovery (i.e., an ANC > 500 cells/mm(3)) in high-risk acute myeloid leukemia (AML) patients with febrile neutropenia (FN). This recommendation is based on expert opinion and the cur...
Autores principales: | Alegria, William, Marini, Bernard L, Perissinotti, Anthony J, Bixby, Dale, Gregg, Kevin, Nagel, Jerod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254200/ http://dx.doi.org/10.1093/ofid/ofy210.264 |
Ejemplares similares
-
2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia
por: Davis, Matthew, et al.
Publicado: (2019) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023) -
Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009) -
Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)